Vaxcyte, Inc.
PCVX· Nasdaq
Released May 9, 2022, after the close
10-Q filed May 9, 2022, 39 days after period end · 0000950170-22-008485
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$38.99M | -$21.22M | -$27.14M | -$13.67M |
| EPS Diluted | -$0.68 | -$0.41 | -$6.70 | -$3.72 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxcyte, Inc. · CIK 1649094 · Engraved from SEC EDGAR